ASX: RAP
Respiratory disease diagnosis using only the sound of a patient’s cough
http://www.nbc-2.com/story/37566213/got-the-flu-help-may-be-just-a-call-or-computer-click-away
https://www.resapphealth.com.au/wp-content/uploads/2018/03/1779894.pdf
Next bio tech company to be running hot once again.
US clinical study due to complete late May with results out June/July.
Expecting trading activity to peak up in the next month or so with investors taking position before end of results.
Current share price as at posting: 12c
Short term price prediction (April/May): 20c~30c
Long term price will be dictated by results obviously. Failure means company will be obliterated.
However I personally believe in the technology and the sky is the limit.
Take your positions.
